Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist
Shasta Tall Bull, Wesley Nuffer, Jennifer Trujillo
Topics & Concepts
MedicineSemaglutideType 2 diabetesGlycated hemoglobinHypoglycemiaDiabetes mellitusWeight lossGlucagon-like peptide 1 receptorAdverse effectAgonistPlaceboInsulin glargineExenatideInternal medicineClinical trialEndocrinologyObesityLiraglutideReceptorAlternative medicinePathologyDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes